Famotidine is generally considered safe for long-term use and carries fewer risks than stronger acid-suppressing medications like proton pump inhibitors (PPIs). However, the bigger issue with taking it indefinitely isn’t safety but effectiveness: your body can develop tolerance to it in as little as 42 hours, meaning the drug gradually loses its ability to control acid even at higher doses.
What the FDA Labels Actually Say
The FDA-approved prescribing information for famotidine lists treatment durations of up to 6 weeks for non-erosive GERD and up to 12 weeks for erosive esophagitis, both at 20 mg twice daily. The label doesn’t include a specific “maintenance” dosage for GERD beyond those windows. For rare conditions involving extreme acid overproduction, like Zollinger-Ellison syndrome, famotidine is prescribed indefinitely at doses adjusted to the individual.
This means most people taking famotidine long-term for ordinary heartburn are using it outside the studied treatment durations. That doesn’t automatically make it dangerous, but it does mean the evidence base for years-long use in typical heartburn patients is thinner than you might expect.
The Tolerance Problem
The most practical concern with long-term famotidine isn’t a side effect. It’s that the drug stops working as well. Your body adjusts to the acid suppression and begins compensating, a process called tachyphylaxis. Research from the University of Colorado School of Medicine found that this tolerance can begin developing within 42 hours of starting the medication. Over time, stomach acid levels can creep back up despite consistent dosing.
This is a key distinction from PPIs, which maintain their acid-suppressing effect over months and years. If you find that famotidine worked well initially but now seems less effective, tolerance is the likely explanation, not a worsening of your condition.
How It Compares to PPIs
Much of the anxiety around long-term acid suppression comes from research on PPIs like omeprazole and pantoprazole. Those drugs suppress acid far more aggressively than famotidine and have been linked to several concerns during prolonged use. Cleveland Clinic notes that PPIs may increase the risk of C. difficile gut infections by altering the bacterial balance in the intestines, may impair calcium absorption enough to raise fracture risk in the hip, wrist, or spine, and may contribute to chronic kidney disease progression.
Famotidine does not carry these same risks at a comparable level. A study published in Frontiers in Medicine examined bone mineral density in long-term users of both drug classes and found no significant association between prolonged H2 blocker use and bone loss. The researchers concluded that H2 blockers like famotidine have “little interference on the absorption of nutrients like calcium and seldom induce bone loss,” even while PPI users in the same study showed measurably lower bone density.
No Increased Dementia Risk
One concern that comes up frequently, especially for older adults, is whether acid-suppressing drugs affect the brain over time. A prospective cohort study published in Gastroenterology tracked adults 65 and older and found no association between H2 blocker use (including famotidine) and incident dementia, cognitive impairment, or decline in cognitive function scores. This held true across all cognitive endpoints measured. As Harvard Health summarizes it, there are “no long- or short-term health risks” that have been established for H2 blockers as a class.
Vitamin B12 Is Worth Watching
The one nutritional concern that does apply to famotidine is vitamin B12 absorption. Stomach acid plays a role in releasing B12 from food, and any drug that reduces acid can interfere with that process. The Mayo Clinic notes that studies have found taking H2 blockers like famotidine daily for a year or more increases the risk of B12 deficiency.
B12 deficiency develops slowly and can cause fatigue, numbness or tingling in the hands and feet, difficulty with balance, and memory problems. If you’ve been taking famotidine for over a year, it’s reasonable to have your B12 levels checked with a simple blood test. The deficiency is easy to correct with supplements or dietary changes once identified, but it can cause lasting nerve damage if it goes unnoticed for years.
What This Means in Practice
Famotidine has a genuinely favorable safety profile compared to PPIs, with no established links to bone loss, kidney disease, or cognitive decline. The two real issues with indefinite use are tolerance, which can undermine the reason you’re taking it in the first place, and a modest increase in the risk of B12 deficiency over time.
If you’ve been on famotidine for months and it’s still controlling your symptoms effectively, the safety data is reassuring. If it’s stopped working well, that’s the tolerance effect, and continuing to take it offers diminishing returns. In either case, treating the underlying cause of your acid reflux through weight management, dietary changes, or evaluating whether you still need daily medication is more productive than defaulting to indefinite use of any acid suppressant.